ABSTRACT
A new HPLC-UV method for the determination of the impurity profile of erythromycin is developed. In contrast to the liquid chromatography described in the European Pharmacopoeia the analysis could be performed at a temperature of 25 degrees C. Erythromycin samples were analysed on an endcapped RP phase with cyanopropyl groups on the surface using gradient elution with 32 mM potassium phosphate buffer pH 8.0 and acetonitrile/methanol (75:25). The aforementioned method shows clear improvements compared to the actual method of the European Pharmacopoeia, which is less selective and sensitive.
Subject(s)
Anti-Bacterial Agents/analysis , Chromatography, High Pressure Liquid/methods , Erythromycin/analysis , Spectrophotometry, Ultraviolet/methods , Technology, Pharmaceutical/methods , Dosage Forms/standards , Drug Contamination/prevention & control , Erythromycin/analogs & derivatives , Guidelines as Topic , Molecular Structure , Quality Control , Reproducibility of Results , TemperatureABSTRACT
A sensitive, precise and accurate quantitative liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the measurement of erythromycin A (EA) and related substances in commercial samples was developed and validated. The samples were chromatographed on a reversed-phase column with a polar endcapping and analyzed by ion trap tandem mass spectrometry in the multiple reaction monitoring (MRM) mode using positive electrospray ionization. The method showed high recovery (>or=98.82%), high sensitivity (lower limit of quantitation of 0.25 ng/mL for EA and less than 7.3 ng/mL for the related substances) and high precision (
